For most of the twentieth century, longevity research had one scoreboard: how long an animal, or a population, lived. Lifespan is easy to measure and hard to argue with. It's also, on its own, a poor proxy for what people actually want, which is more years spent capable and well, not just more years spent alive.
Healthspan is the attempt to measure that second thing: the portion of life spent free of the chronic disease and functional decline that usually arrive in the last years of a long life. A population can gain years of lifespan while healthspan stays flat or even shrinks, if those extra years are spent managing illness rather than avoiding it.
The shift mattered because it changed what counts as a good result in a study. An intervention that extends a mouse's life by 15% but leaves it frail for most of that extra time is a different finding than one that extends both lifespan and the healthy portion of it. Researchers now report healthspan metrics, including grip strength, mobility, cognitive testing, and disease-free survival, alongside raw lifespan, specifically so a result can't be oversold on lifespan alone.
For a reader, the practical takeaway is a question to ask of any longevity headline: lifespan, healthspan, or both? A lot of coverage collapses the two. The original paper usually doesn't.